Cargando…
Coexistence of BCR/ABL1-positive chronic myeloid leukemia and JAK2 V617F-mutated myelofibrosis successfully treated with dasatinib and ruxolitinib
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6439304/ https://www.ncbi.nlm.nih.gov/pubmed/30956968 http://dx.doi.org/10.5045/br.2019.54.1.77 |
| _version_ | 1783407236414963712 |
|---|---|
| author | Yi, Jun Ho Kim, Hye Ryoun |
| author_facet | Yi, Jun Ho Kim, Hye Ryoun |
| author_sort | Yi, Jun Ho |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6439304 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-64393042019-04-05 Coexistence of BCR/ABL1-positive chronic myeloid leukemia and JAK2 V617F-mutated myelofibrosis successfully treated with dasatinib and ruxolitinib Yi, Jun Ho Kim, Hye Ryoun Blood Res Letters to the Editor Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2019-03 2019-03-21 /pmc/articles/PMC6439304/ /pubmed/30956968 http://dx.doi.org/10.5045/br.2019.54.1.77 Text en © 2019 Korean Society of Hematology http://creativecommons.org/licenses/by-nc/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Letters to the Editor Yi, Jun Ho Kim, Hye Ryoun Coexistence of BCR/ABL1-positive chronic myeloid leukemia and JAK2 V617F-mutated myelofibrosis successfully treated with dasatinib and ruxolitinib |
| title | Coexistence of BCR/ABL1-positive chronic myeloid leukemia and JAK2 V617F-mutated myelofibrosis successfully treated with dasatinib and ruxolitinib |
| title_full | Coexistence of BCR/ABL1-positive chronic myeloid leukemia and JAK2 V617F-mutated myelofibrosis successfully treated with dasatinib and ruxolitinib |
| title_fullStr | Coexistence of BCR/ABL1-positive chronic myeloid leukemia and JAK2 V617F-mutated myelofibrosis successfully treated with dasatinib and ruxolitinib |
| title_full_unstemmed | Coexistence of BCR/ABL1-positive chronic myeloid leukemia and JAK2 V617F-mutated myelofibrosis successfully treated with dasatinib and ruxolitinib |
| title_short | Coexistence of BCR/ABL1-positive chronic myeloid leukemia and JAK2 V617F-mutated myelofibrosis successfully treated with dasatinib and ruxolitinib |
| title_sort | coexistence of bcr/abl1-positive chronic myeloid leukemia and jak2 v617f-mutated myelofibrosis successfully treated with dasatinib and ruxolitinib |
| topic | Letters to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6439304/ https://www.ncbi.nlm.nih.gov/pubmed/30956968 http://dx.doi.org/10.5045/br.2019.54.1.77 |
| work_keys_str_mv | AT yijunho coexistenceofbcrabl1positivechronicmyeloidleukemiaandjak2v617fmutatedmyelofibrosissuccessfullytreatedwithdasatinibandruxolitinib AT kimhyeryoun coexistenceofbcrabl1positivechronicmyeloidleukemiaandjak2v617fmutatedmyelofibrosissuccessfullytreatedwithdasatinibandruxolitinib |